Levothyroxine Sodium
NDC Package 50436-5500-2

11-digit billing NDC: 50436550002

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Levothyroxine Sodium is used for the following indications:- As replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. Marketed by Unit Dose Services, this product is identified by NDC 50436-5500 and is authorized under FDA application NDA021210.

Identification & Billing

NDC Package Code
50436-5500-2
Package Description
30 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
50436550002
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Levothyroxine Sodium
Dosage Form
-
Usage Information
Levothyroxine sodium is used for the following indications:- As replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. Specific indications include: primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism. Primary hypothyroidism may result from functional deficiency, primary atrophy, partial or total congenital absence of the thyroid gland, or from the effects of surgery, radiation, or drugs, with or without the presence of goiter. Hypothyroidism- In the treatment or prevention of various types of euthyroid goiters (see and ), including thyroid nodules (see and ), subacute or chronic Iymphocytic thyroiditis (Hashimoto's thyroiditis), multinodular goiter (see and ), and, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Pituitary TSH SuppressionWARNINGSPRECAUTIONSWARNINGSPRECAUTIONSWARNINGSPRECAUTIONS

Regulatory & Marketing

Labeler Name
Unit Dose Services
FDA Application #
NDA021210
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-01-2003
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (50436-5500). Click a package code to view its specific billing and regulatory data.

90 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50436-5500-2 identifies a specific commercial package of 30 tablet in 1 bottle of Levothyroxine Sodium, labeled by Unit Dose Services. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Unit Dose Services on December 01, 2003. The current certification is valid through December 31, 2019.

How is this Unit Dose Services product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50436550002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50436-5500-2
11-Digit CMS (5-4-2)
50436-5500-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.